Print

EU Extends Review Deadline for Solvay Pharmaceuticals, Inc., Abbott Laboratories (ABT) (JOBS) Deal  
1/22/2010 6:43:29 AM

Bookmark and Share

Reuters -- EU regulators extended on Friday their review of U.S. drugmaker Abbott Laboratories' (ABT.N) plan to acquire Belgian peer Solvay Pharmaceuticals (SOLB.BR) after Abbott offered remedies to ease competition concerns.

//-->